GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Mosaic Company (the) (MOS) [hlAlert]

Rating:
Buy MOS
down 5.38 %

Mosaic Company (the) (MOS) rated Buy with price target $55 by Standpoint Research

Posted on: Thursday,  Oct 23, 2014  10:25 AM ET by Standpoint Research

Standpoint Research rated Buy Mosaic Company (NYSE: MOS) on 10/23/2014, when the stock price was $42.86. Since
then, Mosaic Company has lost 5.39% as of 08/27/2015's recent price of $40.55.
If you would have followed this Standpoint Research's recommendation on MOS, you would have lost 5.38% of your investment in 308 days.

The Mosaic Company (Mosaic) is a producer and marketer of concentrated phosphate and potash crop nutrients for the global agriculture industry. The Company operates through business segments: Phosphates, Potash and Offshore. The Phosphates Segment produces phosphate crop nutrients and feed phosphate, which are used in crop nutrients and animal feed ingredients, respectively. The Potash segment mines and processes potash in Canada and the United States, and sells potash in North America and internationally. The Offshore segment produces and/or markets phosphate, potash and nitrogen-based crop nutrients and animal feed ingredients. The Company serves customers in more than 40 countries. As of May 31, 2009, Cargill, Incorporated owned approximately 64.3% of the Company?s outstanding common stock.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/23/2014 10:25 AM Buy
None
42.86 55.00
as of 10/17/2014
1 Week down  -2.06 %
1 Month down  -12.92 %
3 Months down  -14.27 %
1 YTD down  -13.77 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/16/2012 12:25 PM Buy
None
49.27
7/13/2012 3:25 PM Hold
None
55.05
5/3/2012 2:25 PM Buy
None
52.17 65.00
8/18/2010 4:25 PM Hold
None
57.52
4/27/2010 4:25 PM Buy
None
50.95
12/24/2009 9:25 AM Hold
None
60.05
7/23/2009 4:00 PM Buy
None
51.45

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy